PXS 2.44% 8.0¢ pharmaxis ltd

Synairgen collaboration

  1. 108 Posts.
    lightbulb Created with Sketch. 16

    Synairgen (LSE: SNG), a respiratory and drug discovery-focused venture in the UK has received expedited approval rom the UK-based Medicines and Healthcare Products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 (inhaled formulation of interferon-beta 1a) in COVID-19 patients to potentially assist with the global outbreak of this virus.

    On 20 July 2020, Synairgen plc announced positive results from its trial of SNG001, the Company’s wholly-owned inhaled formulation of interferon beta in hospitalised COVID-19 patients. A replay of the webinar hosted 20 July 2020 discussing positive results of SNG001 in hospitalised COVID-19 patients is available here.

    The Phase II double-blind placebo-controlled trial called SG016 recruited 101 patients from 9 specialists sites in the UK during the period 30 March to 27 May 2020 and found that patients receiving SNG001 had a 79% lower risk of developing severe disease compared to placebo and additionally that patients who received SNG001 were more than twice as likely to recover from COVID-19 as those on placebo.

    The company has inked different licensing deals, such as a collaboration in 2015 with Pharmaxis to develop an oral LOXL2 inhibitor to reduce fibrosis in patients with idiopathic pulmonary fibrosis (IPF). By 2017, this agreement was updated as Synairgen received 5 million UK Pounds in upfront payment and circa 17% of any future net partnering proceeds from all fibrotic indications.

    Where does Pharmaxis stand in relationship with SNG001?

watchlist Created with Sketch. Add PXS (ASX) to my watchlist
(20min delay)
Mkt cap ! $31.77M
Open High Low Value Volume
8.5¢ 8.5¢ 8.0¢ $65.63K 804.1K

Buyers (Bids)

No. Vol. Price($)
1 65843 8.0¢

Sellers (Offers)

Price($) Vol. No.
8.2¢ 400000 1
View Market Depth
Last trade - 15.51pm 04/03/2021 (20 minute delay) ?
-0.002 ( 4.76 %)
Open High Low Volume
8.5¢ 8.5¢ 8.0¢ 95365
Last updated 15.43pm 04/03/2021 (live) ?
PXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.